Related Experiment Video

Updated: Jan 10, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.4K

Targeting autoreactive B cells in SLE with anti-9G4 synthetic immune receptor T cells

Meredith Ramba1, Dusan Bogunovic2,3

  • 1Preprint Club, Icahn School of Medicine at Mount Sinai, New York, NY, USA. highlights@preprintclub.com.

Nature Reviews. Immunology
|November 26, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.9K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.8K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.4K
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.9K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.8K

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.4K
Overview
83.4K

Articles linked to this work by shared authors, journal, and citation graph.

High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.

Journal of human immunity·2026

Clinical considerations for immune dysregulation and immunodeficiency in Down syndrome.

Journal of human immunity·2026

Familial pulmonary alveolar proteinosis and type I interferonopathy by mutation of STAT2 (TIMS2).

The Journal of experimental medicine·2026

Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ-mediated inflammatory death program.

Science signaling·2026

Functional studies in a neonate with a DOCK11 VUS guide clinical care.

Journal of human immunity·2026

STAT2 R148 variant: A 16th-century founder mutation and clinical response to high-dose JAK inhibitor therapy.

Journal of human immunity·2026

Immunogenic cell death and tertiary lymphoid structures: bridging tumour cell death and immune organization.

Nature reviews. Immunology·2026

Interleukin-33 and its receptor: multifaceted roles and emerging therapeutic potential.

Nature reviews. Immunology·2026

Epigenetic regulation of B cell tolerance and dysfunction in autoimmune disease.

Nature reviews. Immunology·2026

Immune-mediated excitotoxicity in brain disorders.

Nature reviews. Immunology·2026

Immune surveillance and immune evasion of senescent cells.

Nature reviews. Immunology·2026

Ferroptosis in T cells: mechanisms, biology and translational opportunities.

Nature reviews. Immunology·2026

Outcome-Guided Immunosuppressive Therapy and Clinical Events in Patients With Cardiac Sarcoidosis: An Observational Registry.

Journal of the American Heart Association·2026

Dual Functions of B7-H3-MAPK Signaling Orchestrate Tumor Immunosuppression via Regulating the Plasticity of Myeloid-derived Suppressor Cells and Fibroblasts.

Cancer discovery·2026

Rituximab as Salvage Therapy in Difficult-to-Treat Autoimmune Hepatitis: A Prospective Case Series.

Gastro hep advances·2026

Spatial Transcriptomics and Mechanisms of Immune Checkpoint Inhibitor-Associated Interstitial Nephritis.

Kidney international reports·2026

Exposure-response relationship of sintilimab in advanced gastric cancer: insights from time-dependent pharmacokinetics and biomarker integration for precision immunotherapy.

Frontiers in pharmacology·2026

FcRn Inhibition in Autoantibody-Mediated Autoimmune Diseases: From Broad Immunosuppression to Precision IgG Modulation.

Mediterranean journal of rheumatology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us